Abhya Gupta

2.1k citations

39 papers · 1.4k indexed · 1 hit paper · h-index 13

Impact in

Pulmonary and Respiratory Medicine top 2%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Respiratory and Cough-Related Research
- Inhalation and Respiratory Drug Delivery
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Neonatal Respiratory Health Research
Physiology top 5%
- Sarcoidosis and Beryllium Toxicity Research
- Asthma and respiratory diseases

Papers in ⓘ

Immunology and Allergy 7
- Allergic Rhinitis and Sensitization 5
Pulmonary and Respiratory Medicine 19
- Respiratory and Cough-Related Research 7
- Cystic Fibrosis Research Advances 6
- Neonatal Respiratory Health Research 6
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Chronic Obstructive Pulmonary Disease (COPD) Research 4

Co-authors: Dong Soon Kim (2 shared papers)Nolwenn Juhel (2 shared papers)Moisés Selman (2 shared papers)Kevin Flaherty (1 shared paper)Andrew G. Nicholson (1 shared paper)Kevin M. Brown (2 shared papers)Ganesh Raghu (2 shared papers)Matthias Klüglich (2 shared papers)
Journals: Journal of Allergy and Clinical Immunology (3 papers)ERJ Open Research (3 papers)Pulmonary Pharmacology & Therapeutics (3 papers)Scientific Reports (2 papers)European Respiratory Journal (2 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Abhya Gupta

37 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis 2011 · 811 citations

Peers

Countries citing papers authored by Abhya Gupta

Since Specialization

Citations

This map shows the geographic impact of Abhya Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abhya Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abhya Gupta more than expected).

Fields of papers citing papers by Abhya Gupta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abhya Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abhya Gupta. The network helps show where Abhya Gupta may publish in the future.

Co-authors

The 25 scholars most cited alongside Abhya Gupta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Abhya Gupta Line = papers co-authored together Abhya Gupta links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis New England Journal of Medicine ·Luca Richeldi, Ulrich Costabel, Moisés Selman, Dong Soon Kim, David M. Hansell, Andrew G. Nicholson, Kevin M. Brown, Kevin Flaherty, Paul W. Noble, Ganesh Raghu, Michèle Brun, Abhya Gupta, Nolwenn Juhel, Matthias Klüglich, Roland M. du Bois Hit paper breakdown →	2011	811
2	Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia The Journal of Immunology ·Judith Branger, Bernt van den Blink, Sebastiaan Weijer, Jeffrey B. Madwed, Carina L. Bos, Abhya Gupta, Chan‐Loi Yong, Stephen H. Polmar, Dariusz P. Olszyna, C. Erik Hack, Sander J. H. van Deventer, Maikel P. Peppelenbosch, Tom van der Poll	2002	203
3	Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment Pulmonary Pharmacology & Therapeutics ·Ian P. Hall, Andrew Fowler, Abhya Gupta, Kay Tetzlaff, Michael C. Nivens, Maria Sarno, Helen Finnigan, Eric D. Bateman, E. Rand Sutherland	2015	68
4	Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia Blood ·Judith Branger, Bernt van den Blink, Sebastiaan Weijer, Abhya Gupta, Sander J. H. van Deventer, C. Erik Hack, Maikel P. Peppelenbosch, Tom van der Poll	2003	66
5	Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis Journal of Allergy and Clinical Immunology ·Norbert Krug, Abhya Gupta, Philipp Badorrek, Ruediger Koenen, Meike Mueller, Anna Pivovarova, James Hilbert, Kristiane Wetzel, Jens M. Hohlfeld, Chester C. Wood	2013	47
6	Sequential use of intravenous and oral acyclovir in the therapy of varicella in immunocompromised children The Pediatric Infectious Disease Journal ·Manuel Carção, R. C. Lau, Abhya Gupta, HELEN HUERTER, Gideon Koren, Susan King	1998	27
7	Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study European Respiratory Journal ·James D. Chalmers, Michal Shteinberg, Marcus Mall, Anne E. O’Donnell, Henrik Watz, Abhya Gupta, E. Frahm, Anastasia G Eleftheraki, J. Rauch, Sanjay H. Chotirmall, April Armstrong, Peter Eickholz, Naoki Hasegawa, Wiebke Sauter, Pamela J. McShane	2024	23
8	A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf ERJ Open Research ·James D. Chalmers, Abhya Gupta, Sanjay H. Chotirmall, April W. Armstrong, Peter Eickholz, Naoki Hasegawa, Pamela J. McShane, Anne E. O’Donnell, Michal Shteinberg, Henrik Watz, Anastasia G Eleftheraki, Claudia Diefenbach, Wiebke Sauter	2023	22
9	ADVERSE DRUG REACTIONS FROM BIRTH TO EARLY CHILDHOOD Pediatric Clinics of North America ·Abhya Gupta, Lisa Waldhauser	1997	22
10	A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma Allergy and Asthma Proceedings ·David Miller, Chester C. Wood, Eric D. Bateman, Craig LaForce, Jon Blatchford, James E. Hilbert, Abhya Gupta, Andrew Fowler	2017	22
11	P38 Mitogen Activated Protein Kinase Is Involved in the Downregulation of Granulocyte CXC Chemokine Receptors 1 and 2 During Human Endotoxemia Journal of Clinical Immunology ·Bernt van den Blink, Judith Branger, Sebastiaan Weijer, Abhya Gupta, Sander J. H. van Deventer, Maikel P. Peppelenbosch, Tom van der Poll	2004	17
12	Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis ERJ Open Research ·Peter Nickolaus, Birgit Jung, Juan Sabater, Samuel Constant, Abhya Gupta	2020	14
13	A Case of Nondigitalis Cardiac Glycoside Toxicity Therapeutic Drug Monitoring ·Abhya Gupta, Prashant Joshi, Saeed A. Jortani, Roland Valdes, Þórður Þórkelsson, Zulfikarali Verjee, Sam D. Shemie	1997	12
14	Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well‐Controlled Asthma The Journal of Clinical Pharmacology ·Andy Fowler, Rüdiger Koenen, James Hilbert, Jon Blatchford, Dominik Kappeler, Ewald Benediktus, Chester C. Wood, Abhya Gupta	2017	10
15	An innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic fibrosis: BALANCE-CF^TM1 ERJ Open Research ·Christopher H. Goss, Raksha Jain, Wolfgang Seibold, Anne-Caroline Picard, Ming-Chi Hsu, Abhya Gupta, Isabelle Fajac	2020	9
16	Efficacy and safety of inhaled ENaC inhibitor BI 1265162 in patients with cystic fibrosis: BALANCE-CF 1, a randomised, phase II study European Respiratory Journal ·Christopher H. Goss, Isabelle Fajac, Raksha Jain, Wolfgang Seibold, Abhya Gupta, Ming-Chi Hsu, Sivagurunathan Sutharsan, Jane C. Davies, Marcus Mall	2021	7
17	Efficacy and safety of BI 671800, an oral CRTH2 antagonist, as add on therapy in poorly controlled asthma patients prescribed an inhaled corticosteroid Ian P. Hall, Maria Sarno, Bernd Disse, Sibel Atış, Ekkehard Beck, Eric D. Bateman, Helen Finnigan, Christoph Hallmann, Abhya Gupta, Andrew Fowler	2012	6
18	Safety, pharmacokinetics, and pharmacodynamics of single doses of an oral p38 MAP kinase inhibitor (BIRB 796 BS) in healthy human males a placebo-controlled, randomised study, double blinded at each dose level Journal of Allergy and Clinical Immunology ·Abhya Gupta, Chan‐Loi Yong, Jeffrey B. Madwed, Hildegard Staehle, Chester C. Wood	2002	5
19	Pharmacologic treatment of nausea and vomiting during pregnancy. PubMed ·Paolo Mazzotta, Abhya Gupta, Caroline Maltepe, Gideon Koren, Laura A. Magee	1998	5
20	TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial Thorax ·Lorraine B. Ware, Nima Soleymanlou, Daniel F. McAuley, Vicente Estrada, George A. Diaz, Peter LaCamera, Renee Kaste, Wansuk Choi, Abhya Gupta, Tobias Welte	2023	4

About Abhya Gupta

Abhya Gupta is a scholar working on Immunology and Allergy, Pulmonary and Respiratory Medicine, Physiology, Immunology and Genetics, having authored 39 papers that have together received 1.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (8 papers), Respiratory and Cough-Related Research (7 papers), Cystic Fibrosis Research Advances (6 papers), Neonatal Respiratory Health Research (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Allergic Rhinitis and Sensitization (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (920 citations), Physiology (459 citations), Immunology and Allergy (94 citations), Rheumatology (163 citations) and Immunology (171 citations). Abhya Gupta has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Dong Soon Kim, Nolwenn Juhel, Moisés Selman, Kevin Flaherty, Andrew G. Nicholson, Kevin M. Brown, Ganesh Raghu, Matthias Klüglich, Luca Richeldi and Paul W. Noble. Their work appears in journals such as Journal of Allergy and Clinical Immunology, ERJ Open Research, Pulmonary Pharmacology & Therapeutics, Scientific Reports and European Respiratory Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact